The next generation of protein interaction assays
Next Generation Screening and Precision Mapping (NGIS) Services for Protein-Protein Interactions
Next Interactions, Inc. is a proteomics services company that delivers more complete, sensitive, and precise measurements of protein-protein interactions to our clients in the biopharmaceutical and agricultural fields. Our Next Generation Interaction Screening and Precision Mapping platform technology (NGIS) combines yeast two hybrid with next generation sequencing (NGS-Y2H), bringing conventional yeast two hybrid to the level of mass spectrometry approach thus perfectly complementing it. Our NGIS platform integrates the latest innovations in sequencing, yeast-based protein interaction mapping techniques, and quantitative cell-based reporters. Using cloud-based data delivery, our quantitative protein-protein interaction screens give scientists information-rich data sets with visualizations and bioinformatics analyses that are clear and actionable.
Our mission is to bring the most precise, reliable and comprehensive tool to answer your protein interactions questions, whether precision mapping of known functional interactions, screening for novel protein interactions for basic research, in search of a new drug target, or high throughput compound screening for disrupting known interactions. Using our assays, you would need to do less validation of the protein hits downstream. Ultimately, we accelerate the R&D process for you, save you time & money and get you the results you need.
What are a protein-protein interactions or PPIs?
Protein–protein interactions are the physical contacts of high specificity established between two or more protein molecules. Protein-protein interactions fundamentally underlie the function of biological systems.
Why does measuring protein-protein interactions matter?
Measuring protein-protein interactions is central to understanding the biological basis of disease and for enabling biotechnology to produce products ranging from safer and more effective therapeutics to next-generation foods, materials, and fuels.
Protein Interaction Screening Challenges
Understanding protein interactions can be powerful, but conventional protein interaction screens needed to be improved. Why?
Complete coverage of the interaction space requires analyzing thousands of interaction pairs.
Quantitative measurements are needed to assess the significance of the results.
Conventional Y2H results in too many false positives. Repetition of screens and background controls for statistical rigor reduces false positives.
Effective visualization is required to analyze quantitative and comprehensive results.
Consult our Protein Interaction Screening Experts.
Contact Next Interactions for advice from our scientists about the best approach for shedding light on the protein interactions you need to understand for your research. We can advise you on methods such as the NGS-yeast two-hybrid system, yeast two-hybrid system, how to complement interactome coverage by mass spectrometry, and more.
We Take the Yeast Two-Hybrid System to the Next Generation Level So You Don’t Miss an Interaction
Quantitative scoring and comparison to controls reduce false positives.
Visualization and Display
Access your data anywhere, any time, using our secure data sharing portal.
Tools for Data Analysis
Bioinformatics data analysis provides quantitative statistics.
Understanding of Inheritable Disease
With NGS–Yeast Two-Hybrid assays, find variants of unknown significance using parallel interaction fingerprints.
Novel Therapeutic Target Discovery
Generate interaction profiles for novel isoforms and protein variants.
Support a protein interaction-driven rationale for protein engineering and synthetic biology.
Explore the molecular mechanisms in pathogenesis.